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SUMMARY
In April 2013 the Lancet Oncology published a
series on cancer control in Africa comprising 7
papers (Lancet Oncology vol 14 number 4). The
significance of these papers to Africa’s attempts
at tackling the rapidly rising prevalence of cancer
cannot be over-emphasized. Potentially, these
papers will form the basis of  National policies
aimed at controlling or managing cancer in Africa
for decades to come. University of Ibadan and
her teaching hospital (University College
Hospital, Ibadan) scores another plus as three
of her staff made notable contributions to the
series. African nations and researchers are strongly
encouraged to implement evidence based global
control guidelines, especially those of the WHO,
in the fight against the growing burden of  cancer.
INTRODUCTION
Cancer, to a large extent, is an incurable disease that
afflicts many organisms and systems. In humans the
disease causes significant morbidity and mortality. The
precise cause of cancer is still largely unknown.
Increased life expectancy and the continued presence
of infectious diseases that are associated with risks of
malignancies make cancer an increasing problem in
sub-Saharan Africa1.
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The Lancet Group of  Journals and Lancet
Oncology
The Lancet group of Journals have very high impact
factors and very significant reputations globally. With
the New England Journal of Medicine, these journals
determine the global direction of  evidence based
medical care. The lancet first appeared in Oct 5, 1823
as an independent journal and has published some really
significant studies in medicine.
Some of the landmark papers published in the Lancet
include first reports of  Lister’s antiseptic principle
(1867), Rivers’ insights into shell shock therapy that
led to a better understanding of what is now known
as Post-Traumatic Stress Disorder (1918), Florey’s
announcement on the value of penicillin (1940), the
first published signal that thalidomide was linked to
birth defects (1961), description of new-variant
Creutzfeldt-Jakob disease (1996), and identification of
coronavirus as a possible cause of SARS (2003).
In September 2000 the Lancet oncology was launched
with a focus on publishing interesting, informative, and
practice-changing articles on any topic connected with
clinical oncology. Currently Lancet Oncology has an
impact factor of 22.59. The journal ranks fourth out
of  194 oncology journals worldwide and is the leading
clinical research journal in oncology. The journal is in
the top 0·5% of all scientific journals, of any discipline,
globally (2011 Journal Citation Reports®, ©Thomson Reuters
2012).
Excellence is what the Lancet group of journals have
come to be known for. Studies have to be rigorous
and exact to stand a chance of being published in any
of  the Lancet group of  Journals. Thus, the series on
cancer control in Africa comprising seven papers (table
1) is a significant contribution to the fight against cancer
in the continent. Potentially these papers will form the
foundations of  Africa’s assault on cancer, a group of
diseases whose prevalence is rapidly rising, in Africa.
Cancer control in Africa 1
The first paper of the series gives a perspective on the
epidemiology of  cancer in the African Region and an
overview of  challenges and opportunities in Cancer
Control2. Although cancer currently accounts for onlyFigure 1: Map of Africa
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about 5% of deaths in the African region (table 2), the
cancer burden might be an underestimation due to
lack of appropriate diagnosis, poor access to care,
and low quality of  cancer data systems. Prostate cancer
in men and cervical cancer in women are the most
common cancers in the region. This paper highlights
the challenges facing cancer control in the region and
most of these surround the absence of cancer
prevention and control policy, strategies, and
programmes.
Cancer control in Africa 2
It has been predicted that in a few decades from now
cancer would become a major clinical and public health
issue in sub-Saharan Africa.  Pathology and pathologists
are central to cancer control anywhere in the world.
The state of  pathology services in Africa needs to be
rapidly scaled up qualitatively and quantitatively. This
second paper in the series gives a comprehensive
review of  the central importance of  pathology in
clinical care, research, and public health necessary for
effective cancer control3. Adequate pathology can
benefit cancer control in sub-Saharan Africa in several
ways: improving clinical services, informing cancer
control efforts, aiding the development and
implementation of national cancer control plans,
supporting cancer registration, and supporting various
types of  research, including epidemiology, basic science,
clinical trials, and translational research. Education of
relevant governmental agency staff, policy makers, and the clinical
community about the central role and importance of  pathology
is crucial to increase support for improved pathology services in
the region.
Cancer control in Africa 3
The treatment of cancer in sub-Saharan Africa is the
theme of the third paper in the series4. The challenges
of treatment of different cancers in the sub-region
are discussed and recommendations for improvement
are highlighted. The paper concludes that issues of
cost, infrastructure, inadequate workforce, cultural
barriers, and scarcity of data all limit cancer care in
sub-Saharan Africa. Oncologists and surgeons must
also intervene to influence the curricula of  medical
schools and training for other health-care professionals,
to improve cancer care. More specialist centres for
oncology care need to be created on the continent to
help in the training of needed health-care workers and
collaborate with international training institutions to
meet the needs of the rapidly growing numbers of
patients with cancer.
Cancer control in Africa 4
With the reduction in the morbidity and mortality due
to communicable diseases in the continent over the
past centuries, the true burden of non-communicable
diseases like cancer is being uncovered. The fourth
paper in the series discusses radiotherapy as an
important component of cancer control5. Progress has
been made in the establishment of  radiation oncology
services in some African countries. Nevertheless, a large
shortfall still exists for basic radiation services and
much work is needed to keep pace with the
burgeoning populations of  many African countries.
Cancer control in Africa 5
The cancer burden in developing countries is growing
rapidly. Pain is a common component of  cancer in all
categories of  patients with the diseases. The
management of pain is a significant aspect of cancer
control. WHO recommends opioid analgesics for the
treatment of moderate to severe pain such as that of
patients with advanced cancer, and regards morphine
as an essential drug. Concrete evidence exists that
opioids are safe and effective for the treatment of
moderate or severe pain in people with cancer.
However, clinicians, patients, and policy makers
regularly over estimate the risks of opioids, believing
them to be more addictive, prone to misuse, and likely
to cause side effects than is suggested by the evidence.
This paper discusses the state of palliative care and
use of morphine in Uganda, Kenya, and Nigeria and
describes a stepwise process map for access to opioid
analgesics6. To ensure improved access can be sustained
longterm; efforts should be made to introduce pain
relief into the curriculum of nursing and medical
schools, with emphasis on procurement, storage,
distribution, and administration of  opioids.
Cancer control in Africa 6
Research aimed at improving palliative care for patients
with cancer is needed to address the problem of
inadequate access to pain control measures7. Much has
been achieved in palliative care in Africa during the
past few years. Innovative forms of  palliative care,
such as roadside care delivered by Hospice Africa
Uganda are practised in the continent, together with
consultancy to other care settings such as hospital wards
and (more rarely) hospital-based palliative care. These
innovations have remained largely unreported in
scientific literature. Research into the needs, care, and
outcomes of patients with advanced cancer in sub-
Saharan Africa is urgently needed for effective cancer
control. Policy makers need evidence for the needs of patients
and the effectiveness of  care. The four pillars of  policy,
education, drug availability, and implementation cannot
achieve integration of palliative care into the public
health system without the generation of  high-quality,
locally relevant evidence for how to achieve each pillar.
A fifth pillar of research activity will ensure that practice
is evidence-based and replicable, that public health
responses reflect the needs and priorities of the
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Paper Authors Focus
Cancer control in Africa 1;
Challenges and opportunities in
cancer control in Africa: a
perspective from the African
Organisation for Research and
Training in Cancer
Imran O Morhason-Bello (M.Sc), MPH
Folakemi Odedina (PhD),




Isaac F Adewole (FAS)
This paper discusses the present situation in
sub-Saharan Africa and proposes ideas to
advance cancer control in the region, including
the areas of cancer awareness, advocacy,
research, workforce, care, training, and funding.
Cancer control in Africa 2;
Improvement of pathology in sub-
Saharan Africa
Adekunle Adesina (MD),
David Chumba  (MD),
Ann M Nelson (MD),
Jackson Orem (MD),
Drucilla J Roberts (MD),
Henry Wabinga (MD),
Michael Wilson (MD),
Timothy R Rebbeck (PhD)
This paper proposes approaches to improving
the status of pathology in Sub-Saharan Africa
and to address the needs of patients with cancer
and other diseases.
Cancer control in Africa 3;
Treatment of cancer in sub-
Saharan Africa
T Peter Kingham (MD),
Olusegun I Alatise (MD),
Verna Vanderpuye (MD),
Corey Casper (MD),
Francis A Abantanga (MD),
Thaim B Kamara (MD),
Olufunmilayo I Olopade (MD),
Muhammad Habeebu (MBBS),
Fatimah B Abdulkareem (MBBCh),
Lynette Denny (MD)
This paper describes treatment options for
patients with cancer in sub-Saharan Africa, with
a focus on the role of surgery in relation to
medical and radiation oncology, and argues that
surgery must be included in public health efforts
to improve cancer care in the region.
Cancer control in Africa 4;
Status of radiotherapy resources in
Africa: an International





Debbie Van der Merwe (PhD),
Eduardo Zubizarreta (MD),
Eduardo Rosenblatt (MD)
A longitudinal assessment of the status of
radiation oncology resources in Africa to
measure the extent of the problem and the
effects of programmes designed to enhance
radiation services in the continent.
Cancer control in Africa 5;
Improving access to analgesic












Data suggest that at least 88% of cancer deaths
with moderate to severe pain are untreated in
the region. Efforts underway in Uganda, Kenya,
and Nigeria provide examples of challenges
faced and innovative approaches adopted and
form the basis of a proposed framework to
improve access to pain relief for patients with
cancer across the region.
Cancer control in Africa 6;












Palliative care for patients with cancer in Africa
currently receives far less research attention
than does palliative care for patients with
HIV/AIDS, but in view of projected increasing
cancer incidence in the region, generation of
local evidence to inform and allow assessment
of palliative care for patients with cancer is
urgently needed.
Cancer control in Africa 7;
Developing cancer control plans in
Africa: examples from five
countries
Daniela Cristina Stefan (PhD),
Ahmed M Elzawawy (MD),
Hussein M Khaled (MD),
Fabien Ntaganda (MMed),
Anita Asiimwe (MPH),
Beatrice Wiafe Addai (PhD),
Seth Wiafe (MPH),
Isaac F Adewole (FAS)
Examples from South Africa, Egypt, Nigeria,
Ghana, and Rwanda describe the state of
national cancer control plans and their
implementation.
Table 1: Summary of  papers in the lancet series on cancer control in Africa
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populations they serve, and that feasible, acceptable,
and effective care is provided.
Cancer control in Africa 7
The final paper of the series describes developing
cancer controls plans in Africa using examples from
five countries; South Africa, Egypt, Nigeria, Ghana,
and Rwanda8. Cancer treatment is resource-intensive
and costly, and because most patients present late, their
survival is short. People affected by cancer rarely
develop political influence (e.g., as politically active
survivor groups) because most patients do not live
long enough. Improved awareness of the increasing
burden of cancer and increased advocacy are needed
to put pressure on governments to develop, fund, and
implement national cancer control plans across the
continent.
Contributors from University of Ibadan/
University College Hospital, Ibadan, Nigeria









He is also an adjunct
Professor at North-
western University,
Chicago, IIlinois, USA, and currently the Vice
Chancellor (11th) of the University of Ibadan, Nigeria.
His current research interests include evaluating novel
ideas for promoting cervical cancer screening in
developing countries, a multi-country study on HPV
in cervical cancer among African women and
evaluating attitudes of HIV positive pregnant women
to contraception and couple counselling. He has
published numerous articles in peer-reviewed journals
and books on gynaecological oncology, abortion,
HIV/AIDS and perinatal medicine. He has delivered
many guest lectures, numerous communications at
scientific conferences, abstracts and poster presentations
and has published over 140 articles in peer-reviewed
journals and books on gynaecological oncology,
abortion, HIV/AIDS and perinatal medicine.
Prof Olaitan Soyanwo: Professor of Anesthesia and
Consultant in Anesthesia and Pain and Palliative Care




care in Africa and
around the world.
She has been an
active member of the
I n t e r n a t i o n a l
Association for Study





on the IASP Council.
She has also served as President of  the Society for the
Study of Pain, Nigeria (IASP chapter), and as a board
member of the African Palliative Care Association,
the Nigeria Hospice and Palliative Care Association,
and the Nigerian Academy of Science. In 2009, she
jointly organized the 9th IASP Research Symposium,
“A Global Problem: Cancer Pain from the Laboratory
to the Bedside,” and co-edited the IASP Press book,
Cancer Pain: From Molecules to Suffering. Referred
to as the “grandmother of pain and palliative care” in
Nigeria, she is described as “tirelessly and courageously”
moving the field of pain forward.
Dr. I. O. Morhason-Bello: Is a lecturer at the
Department of  Obstetrics and Gynaecology, Faculty
of Clinical Sciences, College of Medicine, University
of Ibadan and Honorary Consultant at University
College Hospital, Ibadan, Oyo State, Nigeria. He is a
Fellow of  West African College of  Surgeon (FWACS)
and Fellow of  Medical College of  Obstetrics and
Gynaecology (FMCOG). He has Masters of  Science
Worldwide (population size 6,437,000,000) Africa (population size 738,000,000)
Deaths, n % total deaths Deaths, n % total deaths
Total deaths 58,772 100 11,248 100
Deaths from communicable, maternal,
perinatal, and nutritional diseases
17,971 30.6 7,682 68.3
Infectious or parasitic diseases 9,579 16.3 4,849 43.1
Deaths from non-communicable
Disorders
35,017 59.6 2,797 24.9
Cancers 7,424 12.6 480 4.3
Deaths from other causes 5,784 9.8 769 6.8
Table 2: Death (x1000) by cause worldwide and in Africa in 2004





Ibadan – one of
the first set
graduating student
of  the Postgraduate
training program
supported by The Bill and Melinda Gates Institute and
another Masters in Public Health in Epidemiology track
from the University of Liverpool, United Kingdom.
He is a member of Society of Obstetrics and
Gynaecology of  Nigeria (SOGON). He was the
former secretary of  Nigerian Medical Association, Oyo
State Branch. Dr. Morhason-Bello has several
publications in peer review journals, conference
proceedings and published abstracts that span various
aspects of reproductive health. He is interested in
Urogynaecology, Gynae-oncology and Safe
Motherhood.
CONCLUSIONS
Cancer rates in African countries are rapidly rising.
These publications in the Lancet Oncology are good
baselines for co-ordinated, evidence based approach,
to cancer control in the continent. We must do all that
is required to halt the rising rates and prevent the
epidemic of cancer in Africa. Reversing the trend will
require mass public enlightenment campaigns, lifestyle
modifications, and increased funding from public and
private agencies. Africa must join the global efforts
aimed at conquering cancer by developing required
infrastructure and training adequate manpower.
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